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Summary
The Ca2+ content in the sarcoplasmic reticulum (SR) determines the amount of
Ca2+ released, thereby regulating the magnitude of Ca2+ transient and contraction in
cardiac muscle. The Ca2+ content in the SR is known to be regulated by two factors: the
activity of the Ca2+ pump (SERCA) and Ca2+ leak through the ryanodine receptor (RyR).
However, the direct relationship between the SERCA activity and Ca2+ leak has not
been fully investigated in the heart. In the present study, we evaluated the role of the
SERCA activity in Ca2+ leak from the SR using a novel saponin-skinned method
combined with transgenic mouse models in which the SERCA activity was genetically
modulated. In the SERCA overexpression mice, the Ca2+ uptake in the SR was
significantly increased and the Ca2+ transient was markedly increased. However, Ca2+
leak from the SR did not change significantly. In mice with overexpression of a negative
regulator of SERCA, sarcolipin, the Ca2+ uptake by the SR was significantly decreased
and the Ca2+ transient was markedly decreased. Again, Ca2+ leak from the SR did not
change significantly. In conclusion, the selective modulation of the SERCA activity
modulates Ca2+ uptake, although it does not change Ca2+ leak from the SR.
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Introduction
Cardiac muscle contraction is regulated by Ca2+ released from intracellular
Ca2+ stores in a region named the sarcoplasmic reticulum (SR), a central player in
excitation-contraction coupling that allows actin-myosin interactions to produce active
tension [1]. Membrane depolarization opens L-type Ca2+ channels, thereby leading to
Ca2+ influx through the sarcolemma. A small increase in [Ca2+]i due to Ca2+ influx can
trigger a large amount Ca2+ release from the SR through the Ca2+ release channel
(ryanodine receptor, RyR) which is known as the Ca2+-induced Ca2+ release mechanism
[2]. The amplitude of the intracellular Ca2+ transient, which determines cardiac
contractility, is largely dependent on the Ca2+ content in the SR [1]. Two important
regulators of the Ca2+ content in the SR are the activity of the Ca2+ pump
(sarco/endoplasmic reticulum Ca2+-ATPase, SERCA), which actively transports Ca2+
from the myoplasm to inside the SR, and Ca2+ leak through the RyR. The amount of
Ca2+ released from the SR is known to exhibit a steep relationship with the Ca2+ content
in the SR, and a small change in the Ca2+ content can produce a large change in the
amount of Ca2+ released [3]. This mechanism is thought to be important for changes in
the activity of SERCA to modulate [Ca2+]i. A recent study revealed that changes in the
amount of Ca2+ leak through the RyR also regulate the Ca2+ content and the amplitude
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of [Ca2+]i under both physiological and pathophysiological conditions [4] [5]. Under
physiological conditions, Ca2+ leak occurs during diastole and can prevent Ca2+
overload upon the increased Ca2+ cycling (such as sympathetic nervous stimulation) [5].
Moreover, a recent report suggested that differences in the amount of Ca2+ leak can
explain the strain differences observed in Ca2+ handling among mouse strains [6]. Under
pathophysiological conditions, such as heart failure, excess Ca2+ leak from the SR
decreases the Ca2+ content in the SR and hence reduces the amount of Ca2+ available to
produce cardiac contractions, possibly due to the phosphorylation of the RyR [4] [7].
Although these two regulators (the SERCA activity and Ca2+ leak) are important for
modulating cardiac contractility, the direct relationship between the SERCA activity and
Ca2+ leak has not been fully investigated due to the lack of ideal models to estimate
these two activities separately in the same experimental sample and the difficulty of
selectively modulating the SERCA activity in vitro. The Ca2+ leak function has been
investigated in single cardiomyocytes using Ca2+ spark measurement [8] and
pharmacological inhibition of Ca2+ leak [7] and in the lipid bilayer using electrical Ca2+
flux measurement [9]. In contrast, the Ca2+ uptake function has been estimated in
microsomal fraction- enriched SR using fluorescence dye or radioisotopes [10].
Therefore, it is difficult to estimate Ca2+ uptake and Ca2+ leak separately in the same
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experimental sample using the above methods.
Recently, we reported a novel method to estimate Ca2+ uptake and Ca2+ leak
separately in the same preparation using saponin-skinned mouse left ventricular
preparations [5]. We also created two transgenic mouse models of selectively increasing
or decreasing the SERCA activity [10] [11]. In the present study, we investigated the
direct interaction between the SERCA activity and Ca2+ leak using the saponin-skinned
method combined with transgenic mouse models in which the SERCA activity was
selectively modulated. We also determined the changes in the level of [Ca2+]i and
contractions in these transgenic mouse models to estimate the relationship between the
SERCA activity and Ca2+ leak under beat to beat conditions.
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Materials and Methods

Animals
All experiments were performed in accordance with the Guidelines on Animal
Experimentation of The Jikei University School of Medicine. The study protocol was
approved by the Animal Care Committee of The Jikei University School of Medicine
(Approval number: 19-049C1). The investigation conformed to the Guidelines for the
Care and Use of Laboratory Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996).
Transgenic (TG) mice with cardiac-specific overexpression of rabbit cardiac
SERCA (SERCA-TG) were generated under the control of the cardiac α-MHC gene
promoter in the C57BL/6 background using the same procedure we previously
employed to generate mutant SERCA2 (K397/400E)-overexpression mice [10].
Genotyping was performed to identify mice with the transgene using the following
primers: 5’- AGG AGA AGG ACG GAC AAG GA -3’ and 5’- TGG AGG AGG TGG
CAG AAA CA -3’. Non-transgenic littermate (NTG) mice were used as controls. The
SERCA-TG mice were born in the expected Mendelian ratios and had a normal life
span as wild-type mice.
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The generation of mice with a cardiac-specific overexpression of sarcolipin
(SLN-TG) has been previously reported [11]. Briefly, flag-tagged SLN was
overexpressed under the control of the cardiac β-MLC gene promoter in the FVB
background, and genotyping was performed in the mice with flag-tagged SLN using the
following primers: 5'-CAG CCT CTG CTA CTC CTC TTC CTG CCT GTT C-3' and
5'-GTA GGA CCT CAC AAG GAG CCA AAT AAG-3'. NTG mice were also used as
control. The SLN-TG mice were born in the expected Mendelian ratios and had a
normal life span compared with wild-type mice. The left ventricular pressure and heart
rate values were also the same between the SLN-TG mice and NTG mice (data not
shown). No major Ca2+ handling proteins, including SERCA, were altered. The SERCA
activity was significantly decreased in the SLN-TG mice hearts, without changes in
sensitivity to the Ca2+ concentration, as previously described [11].

Preparations
The papillary muscles or trabeculae dissected from the left ventricle of 10- to
12-week-old mice were used for the experiments [5] [12]. The hearts were quickly
removed from mice anesthetized with sodium pentobarbital (200-300 mg/kg i.p.). The
aorta was cannulated with a blunted 18G needle, and the heart was mounted on a
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Langendorff apparatus perfused with Tyrode’s solution containing 2 mmol/L of Ca2+ at
constant pressure for five minutes [5] [12]. The heart beat was completely stopped by
changing the solution to a solution containing 20 mmol/L of 2, 3-butanedione
monoxime (BDM) (Nacalai Tesque, Inc., Kyoto, Japan). The left ventricle was opened,
and the papillary muscles or thin trabeculae were dissected.

Measurement of intracellular Ca2+ transient and isometric tension
A Ca2+ sensitive photoprotein aequorin was used to measure the intracellular
Ca2+ transient (CaT) simultaneously with isometric tension in the left ventricular
papillary muscle preparations [12]. The aequorin was microinjected into 50-100
superficial cells of each preparation by applying high pressure with nitrogen gas using
glass micropipettes. The preparation was electrically stimulated with platinum
electrodes (1 mmol/L Ca2+, 0.5 Hz, 30°C) and the evoked aequorin light signal was
recorded using a photomultiplier (EMI9789A, Ruislip, UK) simultaneously with
measurement of the isometric tension (BG-10, Kulite, NJ, USA). The aequorin light
signals were averaged and converted to the intracellular Ca2+ concentration using in
vitro calibration [13].
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Measurement of the Ca2+ content in the SR
The method used to estimate the SR function has been previously reported
(Supplementary Figure I) [5] [14]. Briefly, the papillary muscles or trabeculae were cut
along the longitudinal axis (≅200 µm× 2-5 mm) in the experimental solution and both
ends of the preparation were tied to a tungsten wire with silk threads. Then, the
preparation was permeabilized with saponin (50 µg/ml) in the relaxing solution for 30
minutes and inserted into a glass capillary tube placed on an inverted microscope
(Nikon, Tokyo, Japan). An excitation light wavelength of 488 nm and emission
wavelength of longer than 510 nm through a cut-off filter (DM-510, Nikon, Tokyo,
Japan) were used to monitor the fluorescence signal of fluo-3 (Dojindo Laboratories,
Kumamoto, Japan) using a fluorometry system (CAM-230, JASCO, Tokyo, Japan).
In the Ca2+ uptake assay (Supplementary Figure IA-D), after the SR was loaded
with Ca2+ by activating SERCA with adenosine triphosphate (ATP) (4 mmol/L),
caffeine (50 mmol/L) was applied to release the accumulated Ca2+ from the SR into the
experimental solution containing fluo-3 (30 µM). As fluo-3 predominantly binds most
of the Ca2+ released from the SR, the fluo-3 fluorescence change upon Ca2+ binding
provides an estimate of the amount of accumulated Ca2+ in the SR before caffeine
application. In the Ca2+ leak assay (Supplementary Figure IE-H), the preparation was

10

perfused
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experimental
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containing

ethylene

glycol

bis[β-aminoethylether]-N, N, N’,N’-tetraacetic acid (EGTA) (1 mmol/L) for various
durations following Ca2+ loading, and then the remaining Ca2+ was measured using the
same protocol. We then estimated the maximal Ca2+ content, which reflects the level of
Ca2+ fully-loaded in the SR, by extrapolating of the sampling point of each Ca2+ content
to reach the Ca2+ content at time zero. The amount of Ca2+ leak was estimated by
subtracting the remaining Ca2+ content from the maximal Ca2+ content (see the
Supplementary Data for details).

Solutions and chemicals
Tyrode’s solution buffered with N-2-hydroxyethyl-piperazine-N-2ethanesulfonic acid (HEPES) was used for Langendorff perfusion of the hearts,
dissection of the preparations and the aequorin experiment. The composition of the
Tyrode’s solution was as follows: 136.9 mmol/L of NaCl, 5.4 mmol/L of KCl, 0.5
mmol/L of MgCl2, 1-2 mmol/L of CaCl2, 0.33 mmol/L of NaHPO4, 5 mmol/L of
HEPES and 5 mmol/L of glucose. The pH was adjusted to 7.40±0.05 with NaOH at
30°C, and the solution was equilibrated with 100% O2.
The solutions used to estimate the SR function was based on potassium
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methanesulfonate (KMS) (103–164 mmol/L) to maintain a constant ionic strength under
various conditions. The Ca2+ concentration was below pCa8, except for the “loading”
period (between pCa8 and pCa5.6). The experimental solution contained 20 mmol/L of
NaN3 to block the Ca2+ uptake in the mitochondria and 20 mmol/L of
piperazine-N-N’-bis[2-ethanesulfonic acid] (PIPES) (ionic strength, 0.2 mol/L;
temperature, 22°C; pH adjusted with KOH). ATP (4 mmol/L) was present during the
“load” period to activate the SERCA in the loading step. Each assay solution contained
50 mmol/L of caffeine and 25 mmol/L of adenosine-5’-monophosphate (AMP) to open
the Ca2+ release channel (RyR) of the SR effectively. Fluo-3 was added to the
“pre-assay” and “assay” solutions at a final concentration of 30 µM [5] [14] (see
Supplementary Table 1 for details).
All reagents were purchased from Sigma (Saint Louis, MO), unless otherwise
indicated.

Statistics
All measured data are presented as the means ± standard error of the mean
(SEM). Statistical significance was estimated using the unpaired Student’s t-test for two
sets of data and using a one-way analysis of variance (ANOVA) followed by the

12

Bonferroni post-hoc test for multiple comparisons, with the significance level set at
p<0.05. All statistical analyses were performed using the SPSS software program
version 11.5 (SPSS Inc., Chicago, IL, USA).
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Results

Protein expression levels and hemodynamics of the SERCA-TG mice
In the hearts of the SERCA-TG mice, the SERCA protein levels were
significantly increased (1.68±0.10-fold increase) compared to those observed in the
NTG mice, as demonstrated by Western immunoblotting (n=3 for SERCA-TG, n=3 for
NTG) (Supplementary Figure II). No other major Ca2+ handling proteins were altered.
The left ventricular pressure and heart rate values were the same between the
SERCA-TG mice and NTG mice (n=6 for SERCA-TG, n=6 for NTG) (Supplementary
Figure III).

Effects of selective upregulation of the SERCA activity on the Ca2+ transient and
isometric tension in the intact preparations
First, we investigated the Ca2+ handling and contractions in the SERCA-TG
heart. We evaluated the Ca2+ transient and isometric tension under field stimulation at
0.5 Hz, because the contractility of the isolated muscle preparation is stable at a lower
stimulation frequency during the long period of the experiments [12]. However, we also
evaluated these under a higher stimulation frequency (up to 2 Hz) and found similar
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results to those observed at 0.5 Hz (data not shown). The left graphs of Figure 1 present
representative traces of the Ca2+ transient (A) and isometric tension (B) recorded from
the intact papillary muscle preparations of the SERCA-TG and NTG hearts. The peaks
of the Ca2+ transient and isometric tension were significantly increased in the
SERCA-TG hearts compared to that observed in the NTG hearts (p<0.05) (n=6 for
SERCA-TG, n=8 for NTG). The time to reach the peak of the Ca2+ transient (TP) did
not change significantly; however, the decay time of the Ca2+ transient from the peak to
half of the peak (DT) was significantly shortened in the SERCA-TG hearts (p<0.01).
Both the time to reach the peak of tension (TPT) (p<0.01) and the relaxation time from
the peak tension to half the peak (RT) (p<0.01) were significantly shortened in the
SERCA-TG hearts.

Effects of selective upregulation of the SERCA activity on the SR function in the
saponin-treated preparations
We then estimated the SR function in the SERCA-TG hearts. Figure 2A shows
the time-dependent changes in Ca2+ uptake into the SR estimated in the loading solution
at pCa7 using the saponin-skinned preparations (n=13 for SERCA-TG, n=8 for NTG).
The amount of Ca2+ uptake was significantly accelerated in the early phase (less than 10

15

seconds) of Ca2+ loading in the SERCA-TG hearts. Figure 2B shows the
Ca2+-dependent changes in the Ca2+ uptake estimated at the early phase of Ca2+ loading
(n=16 for SERCA-TG, n=16 for NTG). At the fixed loading time of 10 seconds, the
amount of Ca2+ uptake into the SR was significantly increased between pCa7.4 and
pCa6.6 in the SERCA-TG hearts. The maximal Ca2+ content was estimated in the
SERCA-TG and NTG hearts. As shown in Figure 2C, the maximal Ca2+ content in the
SERCA-TG hearts was not significantly different from that observed in the NTG hearts
(n=29 for SERCA-TG, n=24 for NTG).
Finally, we investigated Ca2+ leak from the SR under the selective
overexpression of SERCA. Figure 2D shows the time-dependent changes in Ca2+ leak
from the SR (n=29 for SERCA-TG, n=24 for NTG). The time course of Ca2+ leak was
identical between the SERCA-TG and NTG hearts.

Effects of selective downregulation of the SERCA activity on the Ca2+ transient
and isometric tension in the intact preparations
In the next series of experiments, we investigated the role of the selective
downregulation of SERCA on E-C coupling using SLN-TG hearts. We first estimated
the Ca2+ transient and isometric tension of the intact papillary muscle preparations

16

obtained from the SLN-TG and NTG mice. The left graphs of Figure 3 show the
representative traces of the Ca2+ transient (A) and isometric tension (B) recorded from
the preparations of the SLN-TG and NTG hearts. Both the peak of the Ca2+ transient
(p<0.01) and the peak of tension (p<0.01) were significantly decreased in the SLN-TG
hearts (n=7 for SLN-TG, n=10 for NTG). The TP did not significantly change, whereas
the DT was significantly prolonged in the SLN-TG hearts (p<0.01). Both the TPT
(p<0.05) and RT (p<0.01) were significantly prolonged in the SLN-TG hearts.

Effects of selective downregulation of the SERCA activity on the SR function in the
saponin-treated preparations

We then estimated the SR function in the SLN-TG and NTG hearts using the
saponin-skinned preparations. The amount of Ca2+ uptake was significantly attenuated
in the early phase (less than 15 seconds) of exposure to the loading solution at pCa6.2 in
the SLN-TG hearts (Figure 4A) (n=11 for SLN-TG, n=12 for NTG). At the fixed
loading time of 15 seconds, the amount of Ca2+ uptake was significantly decreased
between pCa6.6 and pCa6.2 in the SLN-TG hearts (Figure 4B) (n=18 for SLN-TG,
n=16 for NTG). We also estimated the maximal Ca2+ content in the SR and found no
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significant differences between the SLN-TG and NTG hearts (Figure 4C) (n=29
SLN-TG, n=28 for NTG).
We then estimated the amount of Ca2+ leak under the selective downregulation
of SERCA. The time course of Ca2+ leak from the SR did not differ between the
SLN-TG and NTG hearts (Figure 4D) (n=29 for SLN-TG, n=28 for NTG).
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Discussion
The primary result of the present study is that the selective modulation of the
SERCA activity can produce large changes in the Ca2+ transient without changing the
amount of Ca2+ leak from the SR.
In the present study, we used saponin-skinned preparations to estimate the SR
function, in which a separate estimation of Ca2+ uptake and Ca2+ leak can be made using
the same preparation [5]. A previous report suggests that a large change in the SERCA
activity produces a relatively small change in the Ca2+ content in the SR [3] [15]. In this
study, in the SERCA-TG mouse heart, the expression level of SERCA proteins was
increased 1.68 ± 0.10-fold compared with that observed in the NTG hearts (see
Supplementary Figure II), and the amplitude and time course of the Ca2+ transient was
largely affected (see Figure 1). Although the maximal Ca2+ content was unaltered in the
SERCA-TG hearts, the Ca2+ content of the SR in each beat changed. The Ca2+ content
of the SR during diastole is determined by the balance between Ca2+ uptake and Ca2+
leak in the SR. If changes in the SERCA activity directly modulate Ca2+ leak,
SERCA-dependent changes in the Ca2+ content can be off-set by the altered Ca2+ leak.
However, the lack of significant changes in Ca2+ leak in the SERCA-TG heart does not
support this possibility. We also showed that a selective decrease in the SERCA activity
can produce a large decrease in the amplitude and significant slowing of the time course
19

of the Ca2+ transient in SLN-TG heart preparations. The result showing that the
significant attenuation of Ca2+ uptake did not change the amount of Ca2+ leak from the
SR in the SLN-TG hearts also suggests that changes in the Ca2+ content upon the
selective modulation of the SERCA activity do not have a significant effect on Ca2+ leak.
Under our experimental conditions in which the SERCA activity was chronically
modulated, the maximal Ca2+ content of the SR was not affected, although the Ca2+
content observed under the beat to beat conditions was altered according to the results
of Ca2+ transient measurement (see Figures 1 and 3). The unaltered maximal Ca2+
content of the SR may explain why the selective modulation of SERCA did not
influence Ca2+ leak in our system.
Impairment

of

the

SERCA

activity

is

well

documented

under

patho-physiological conditions. Under conditions of heart failure, reduced Ca2+ uptake
due to inhibition of the SERCA activity has been reported in both animal models and
human failing hearts [16-20]. Therefore, the upregulation of the SERCA activity is a
promising therapeutic strategy for treating heart failure, and recent observations of gene
therapy for heart failure have strongly focused on the SERCA activity as a target of
gene transfer in animal models as well as human heart failure [21-23]. However, the
increase in the SERCA activity also serves to increase the beat to beat Ca2+ content in
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the SR, which can cause Ca2+ leak through the RyR [24]. Abnormal Ca2+ leak through
the RyR has also been extensively investigated in various heart failure models. Marks’s
group originally identified the novel mechanism by which the protein kinase A
(PKA)-dependent phosphorylation of the RyR dissociates FKBP12.6, which in turn
leads to Ca2+ leak through the RyR [4]. The phosphorylation-dependent modulation of
RyR has therefore been considered an important mechanism regulating Ca2+ leak,
especially under pathological conditions such as heart failure and ventricular arrhythmia
[25-26]. Three independent Ser residues in cardiac RyR are known to be phosphorylated
by

protein

kinases.

PKA

mainly

phosphorylates

Ser2808

whereas

Ca2+/calmodulin-dependent protein kinase II (CaMKII) mainly phosphorylates Ser2814
[27]. Ser2030 is also a target of PKA-dependent phosphorylation in RyR, however, the
importance of this residue is questionable [28]. The first report stated that the
PKA-dependent hyperphosphorylation of RyR2 accelerated the dissociation of
FKBP12.6 from RyR, which destabilized the Ca2+ release channel to increase Ca2+ leak
[4]. This idea is fits well with the increased activity of the sympathetic nervous system
in subjects with heart failure. However, other experimental data suggested that the
CaMKII-dependent phosphorylation of RyR is important for pathological Ca2+ leak [7]
[29-30]. In addition, the identification of an exchange protein that was directly activated
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by

cAMP (Epac)

further

supported

the

importance

of

CaMKII-dependent

phosphorylation through beta-adrenergic receptor stimulation in the heart [31-33]. Very
recently, it has been reported that both CaMKII and PKA functionally regulate RyR but
have differential roles in human cardiac pathology [34]. Therefore, abnormal Ca2+ leak
through the RyR may play a significant role in heart failure and may be another
promising target of treatment. Our results demonstrating the absence of changes in Ca2+
leak upon the selective modulation of the SERCA activity support the utility of gene
therapy targeting the SERCA activity. Recent observations in animal models and the
findings of a clinical trial support the favorable effects of SERCA-mediated gene
therapy [35-37].
Recently, another target of gene therapy for Ca2+ handling has been proposed.
S100A1 is an EF-hand Ca2+ binding protein that exhibits a conformational change upon
binding to Ca2+ and interacts with various functional proteins [38]. In cardiac muscle,
S100A1 has been found to modulate the intracellular Ca2+ handling process. For
example, S100A1 interacts with SERCA to increase the SERCA activity and with RyR
to inhibit Ca2+ leak from the SR [39]. S100A1 also modulates the myofilament
sensitivity to Ca2+, which can alter cardiac contractility. Therefore, S100A1 may be the
ideal therapeutic target for treating heart failure due to both the activation of SERCA
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and the inhibition of Ca2+ leak. However, elucidating the role of S100A1 in gene
therapy for heart failure must wait for the results of pre-clinical and clinical trials [40].

Limitations of this study
1) Although we determined the protein expression levels of various functional
modulators in cardiac excitation-contraction coupling, we did not assess the
phosphorylation levels of proteins such as phospholamban and RyR. 2) Our
measurements of the SR function were obtained under in vitro conditions, and the
results must be extrapolated into the heart in vivo. 3) The SERCA-TG and SLN-TG
models are not disease models (the mice did not exhibit heart failure). 4) Both
transgenic mice demonstrated cardiac-specific overexpression, but not conditional
overexpression. 5) Because we used a high concentration of EGTA (1 mmol/L) in the
experimental solution, which might inhibit SERCA activity, the speed of the Ca2+
uptake by SERCA under our experimental conditions is much lower than that observed
under physiological conditions in situ. 6) Because we could not evaluate the detailed
effects of ATP (4 mmol/L) on RyR2 due to the nature of our experimental system used
for the Ca2+ leak assay, we might have underestimated the amount of Ca2+ leak under
our experimental conditions at (physiological) nmol/L levels of cytosolic Ca2+ [41] [42].
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Conclusion
In the present study, we found the selective modulation of the SERCA activity
to have a profound effect on cardiac excitation-contraction coupling due to alteration of
Ca2+ uptake into the SR, without significant changes in Ca2+ leak from the SR. These
results support the utility of gene therapy targeting SERCA and related molecules.
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Figure captions

Figure 1. Ca2+ transient and isometric tension in the intact preparations from the
SERCA-TG hearts
A. The left graph shows representative traces of the Ca2+ transient from the left
ventricular papillary muscle in the SERCA-TG (red) and NTG (black) hearts. The bar
graphs show the amplitude, time to reach the peak (TP) and decay time from the peak to
half of the peak (DT) of the Ca2+ transient in the SERCA-TG (red) and NTG (black)
hearts.
B. The left graph shows representative traces of isometric tension in the preparations
obtained from the SERCA-TG (red) and NTG (black) hearts. The bar graphs show the
amplitude, time to reach the peak (TPT) and relaxation time from the peak to half of the
peak (DT) of tension in the SERCA-TG (red) and NTG (black) hearts.

Figure 2. Sarcoplasmic reticulum function in the saponin-treated preparations from the
SERCA-TG hearts
A. The time-dependent changes in Ca2+ uptake into the SR during exposure to the
loading solution at pCa 7.
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B. The Ca2+ uptake estimated at 10 seconds of exposure to the loading solution of
various pCa.
C. The maximal Ca2+ content of the SR in the SERCA-TG and NTG hearts.
D. The time-dependent changes in Ca2+ leak from the SR following Ca2+ loading at pCa
6.2 for 120 seconds.

Figure 3. Ca2+ transient and isometric tension in the intact preparations from the
SLN-TG hearts
A. The left graph shows representative traces of the Ca2+ transient from the left
ventricular papillary muscle in the SLN-TG (green) and NTG (black) hearts. The bar
graphs show the amplitude, time to reach the peak (TP) and decay time from the peak to
half of the peak (DT) of the Ca2+ transient in the SLN-TG (green) and NTG (black)
hearts.
B. The left graph shows representative traces of isometric tension in the preparations
obtained from SLN-TG (green) and NTG (black) hearts. The bar graphs show the
amplitude, time to reach the peak (TPT) and relaxation time from the peak to half of the
peak (DT) of tension in the SLN-TG (green) and NTG (black) hearts.

34

Figure 4. Sarcoplasmic reticulum function in the saponin-treated preparations from the
SLN-TG hearts
A. The time-dependent changes in Ca2+ uptake into the SR during exposure to the
loading solution at pCa 6.2.
B. The Ca2+ uptake estimated at 15 seconds of exposure to the loading solution of
various pCa.
C. The maximal Ca2+ content of the SR in the SLN-TG and NTG hearts.
D. The time-dependent changes in Ca2+ leak from the SR following Ca2+ loading at pCa
6.2 for 120 seconds.
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Supplementary Data

Expanded Materials and Methods

Western immunoblotting

Western immunoblotting was performed to confirm the amount of
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) and other Ca2+-handling proteins
as previously described [1]. Briefly, proteins obtained from myocardial tissue of
SERCA-TG (n=3) and NTG (n=3) mice were prepared and subjected to a Western
immunoblotting analysis using the following antibodies: SERCA (N-19, Santa Cruz
Biotechnology, Santa Cruz, CA), phospholamban (PLN) [2], Na+/Ca2+ exchanger
(NCX) [3], ryanodine receptor (RyR) [4] and cardiac actin (Sigma, St. Louis, MO). The
protein expression level was normalized to that of cardiac actin.

Assessment of the left ventricular pressure and heart rate in vivo

Mice were anesthetized via an intra-peritoneal injection of a mixture of
ketamine (50-100 mg/kg) and xylazine (3-6 mg/kg). The right carotid artery was
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isolated and cannulated with a 1.4 French Millar (Houston, TX) catheter connected to
an amplifier (TCP-500, Millar). Then, the catheter was advanced into the left ventricle
and the left ventricular pressure was digitized and processed by a computer system
(model PE-1000; Nihon Kohden, Tokyo, Japan). The heart rate was monitored
simultaneously.

Estimation of the Ca2+ uptake and Ca2+ leak of the SR

We used a series of solutions to measure the Ca2+ content in SR, as shown in
Supplementary Table 1. To estimate the Ca2+ uptake, Ca2+ was loaded into the SR by
activating the Ca2+ pump in the presence of ATP (4 mmol/L) at various times (10-120
sec) after loading with solutions containing different Ca2+ concentrations (pCa 8-5.6)
(Supplementary Figure IA). The Ca2+ and ATP around the SR were then removed using
a washing solution containing O, O’-Bis (2-aminoethyl) ethyleneglycol-N, N, N’,
N’-tetraacetic acid (EGTA) (1 mmol/L), to terminate the Ca2+ uptake of the SR
(Supplementary Figure IB). Then, the preparation was perfused with pre-assay solution
containing fluo-3 (30 µM) (Supplementary Figure IC). Finally, all Ca2+ in the SR was
released using a high concentration of caffeine (50 mmol/L) and AMP (25 mmol/L), and
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the Ca2+ -dependent fluorescence change was measured using fluo-3 (Supplementary
Figure ID). The measured change in the fluorescence of fluo-3 was converted to the
Ca2+ concentration, and the amount of Ca2+ in the SR was shown in units of µmol/L
cytoplasm.

To estimate the Ca2+ leak, the preparation was perfused with the washing
solution containing EGTA for various durations of time (15-300 sec) (Supplementary
Figure IF) following Ca2+ loading (Supplementary Figure IE). Then, the remaining Ca2+
in the SR after washing (15-300 sec) was measured usnig the same protocol as was used
for the Ca2+ uptake assay (Supplementary Figures IG, H). We evaluated the maximal
Ca2+ content of the SR based on the fitting curve of the Ca2+ leak, and the value of the
Ca2+ content before washing was estimated as the maximal Ca2+ content. Finally, the
amount of Ca2+ leak was estimated by subtracting the remaining Ca2+ in the SR from the
maximal Ca2+ content. We validated the Ca2+ leak measurement using ruthenium red to
inhibit RyR opening (Supplementary Figure IV).

Use of aequorin to measure the intracellular Ca2+ transient
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We used aequorin to measure the intracellular Ca2+ transient from the intact
preparations for the following reasons: 1) Aequorin is sensitive to changes in the Ca2+
concentration (one molecule of aequorin can bind three Ca2+ ions) [5] and more
accurate estimation of the amplitude and the time course of the Ca2+ transient can be
achieved using aequorin compared with fluorescent dyes such as fura-2 [6]. 2) Upon
binding to Ca2+, aequorin does not cause buffering of Ca2+ due to the consumptive
nature of aeqourin, which overcomes one of the disadvantages of using a fluorescent
dye [5]. 3) Using aequorin enabled us to measure the Ca2+ transient and isometric
tension (not cell shortening) simultaneously [7] [8]. We monitored the membrane
potential of cells at the surface of the preparation during pressure injection to check the
cell condition to avoid excess damage during injection [7] [8].
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Table 1. Composition of the solutions for sarcoplasmic reticulum function

A. Ca2+ uptake assay
period

load

wash

pre-assay

assay

Time (s)
Ca2+ (pCa)
KMs (mM)
Mg2+ (mM)
EGTA (mM)
ATP (mM)
AMP (mM)
caffeine (mM)

10-120
8-5.6
126-128
1.5
1
4
0
0

60
>8
154
1.5
1
0
0
0

30
>8
162
0
0
0
0
0

60
>8
103
0
0
0
25
50

fluo-3 (µM)
PIPES (mM)
NaN3 (mM)

0
20
20

0
20
20

30
20
20

30
20
20

B. Ca2+ leak assay
period

load

leak & wash

pre-assay

assay

Time (s)
Ca2+ (pCa)
KMs (mM)
Mg2+ (mM)
EGTA (mM)
ATP (mM)
AMP (mM)
caffeine (mM)

120
6.2
127
1.5
1
4
0
0

15-300
>8
154
1.5
1
0
0
0

30
>8
162
0
0
0
0
0

60
>8
103
0
0
0
25
50

fluo-3 (µM)
PIPES (mM)
NaN3 (mM)

0
20
20

0
20
20

30
20
20

30
20
20

MS,

methanesulfonate;

EGTA,

ethylene
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glycol

bis[β-aminoethylether]-N,

N,

N’,N’-tetraacetic

acid;

ATP,

adenosine

triphosphate;

AMP

adenosine-5’-monophosphate; PIPES, poperazine-N-N’-bis[2-ethanesulfonic acid]; M,
mol/L.
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